Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vaxil Bio Ltd VXLLF


Primary Symbol: V.VXL

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19... see more

TSXV:VXL - Post Discussion

Vaxil Bio Ltd > 💉 Vaxil Bio == On W.H.O Vaccine Candidate List !🥼
View:
Post by AmandaPearce on Nov 04, 2021 2:20am

💉 Vaxil Bio == On W.H.O Vaccine Candidate List !🥼

Here on this site vaxil bio shows to be a private company.  Maybe investors assume it is privately held?
[url=https://www.globaldata.com/companies/listing/search/?exactWord=1&q[]=Vaccine&location=100003]https://www.globaldata.com/companies/listing/search/?exactWord=1&q[]=Vaccine&location=100003[/url]

The World Health Organization still has Vaxil Bio on the vaccine candidate list.  They should soon be hitting phase 1 trials, expect another advancement soon.
https://www.google.ca/url?sa=t&source=web&rct=j&url=https://cdn.who.int/media/docs/default-source/blue-print/22.10.2021_novel-covid-19-vaccine-tracker.xlsx.zip%3Fsfvrsn%3D7014a7f8_9%26download%3Dtrue&ved=2ahUKEwjS7qPthv7zAhVHmGoFHbQ0DDEQFnoECAQQAQ&usg=AOvVaw0u0PFiLbfvpgBRjPQ6raDh
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities